Stating that mesenchymal stem cell (MSC) and exosome treatments can be applied in cases of heart failure, contraction disorders after heart attack and heart failure not due to vascular occlusion, Cardiology Specialist Dr. Lecturer. Prof. Emre Aksakal, Cardiology Specialist, said, “These treatments aim to increase heart contraction strength and blood circulation.”
Stating that stem cell and exosome therapies are among the groundbreaking innovations in the medical field today, Cardiology Specialist Dr. from VM Medical Park Samsun Hospital. Prof. Emre Aksakal said, “These promising treatments in the treatment of various diseases both accelerate wound healing and provide new formations in the vessels.”
“Cells that repair damaged tissues”
Stating that mesenchymal stem cells (MSCs) are important cells found in connective tissue in our body and repair damaged tissues, Dr. Lecturer. Prof. Dr. Emre Aksakal said, “These cells are multiplied in the laboratory environment and used in treatment. MKH treatments do not have serious side effects and are not rejected by the body.”
Stating that exosomes are the whole of the substances in the structure of multiple proteins released in the production of MSC cells, Dr. Lecturer. Prof. Dr. Aksakal said, “Exosomes are also applied as a separate element in treatment.”
“Preferred in heart diseases”
Stating that MKH and exosome treatments approved by the Ministry of Health can be applied in cases of heart failure, contraction disorders after heart attack and heart failure not due to vascular occlusion, Dr. Lecturer. Prof. Dr. Aksakal said, “These treatments aim to increase heart contractility and blood circulation. In addition, MDR and exosome therapies are effectively used in the healing of foot wounds caused by peripheral arterial diseases (leg vascular occlusion) caused by diabetes and heavy smoking. These treatments both accelerate wound healing and increase walking distance by providing new formations in the vessels and prevent limb loss.”
“The treatment is performed in 2-3 sessions”
Stating that the patient's examination, echocardiography and cardiac MRI results are sent to the Ministry of Health and approval must be given by the committee formed in order to apply MKH and exosome treatments, Dr. Lecturer. Prof. Dr. Aksakal said, “The treatment is usually performed in two or three sessions, and the first application is made to the heart vessel during the angiography procedure. Subsequent applications are usually performed intravenously.” Emphasizing that stem cell and exosome therapies are innovative therapies approved by the Ministry of Health and promising in the treatment of various diseases, Dr. Lecturer. Prof. Dr. Aksakal said, “These treatment methods can be applied in addition to conventional treatments.”
İHA Haber Kodu: 20240821AW271489